LFMDP
LifeMD, Inc.
$24.19
+2.21%
$1.1B
No data for this timeframe.
Vol
Market Cap$1.1B
Cap SizeSmall Cap
SEC Reports1
Exchange Nasdaq·Sector Services-Offices & Clinics of Doctors of Medicine·Inc. DE·CIK 0000948320·Prev Close $23.67
Recent Activity
May 15, 2026
other
LifeMD to Participate in Upcoming Investor Conferences
<p align="justify">NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.c
May 6, 2026
SEC
LifeMD reported Q1 2026 revenue of $50.2M, above the $48-49M guidance range and consensus estimate of $48.9M, with subsc
8-K — Impact 6/10
Analyst Ratings
3Strong Buy
10Buy
1Hold
0Sell
0Strong Sell
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 0 neutral. Avg impact: 6.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 93% buy across 14 analysts — 3 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | -20.8% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | -2.8% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.2B | 14.6% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.3B | 18.2% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 3 | 10 | 1 | 0 | 0 | 93% | |
| Apr 1, 2026 | 3 | 10 | 1 | 0 | 0 | 93% | |
| Mar 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| Feb 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| Jan 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 15, 2026
other
LifeMD to Participate in Upcoming Investor Conferences
<p align="justify">NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=EG8bSW8HTyZm81S1YdUnuXNJA2HMrdmBY5
May 6, 2026
earnings
LifeMD Reports First Quarter 2026 Results
<p align="center"><strong><em>Conference</em></strong> <strong><em>call begins at 4:30 p.m. Eastern time today</em></strong></p>
Apr 27, 2026
earnings
LifeMD to Report First Quarter 2026 Financial Results on May 6
<p align="justify">NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=SQaj39YrNdAnRN4K7zAZiyWQvPqUlB1z
Apr 10, 2026
other
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapi
Mar 31, 2026
contract
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program
Delivering up to $1,200 in annual patient savings on branded GLP-1 therapy, expanding LifeMD’s collaboration with Novo Nordisk <pre>Delivering up to $
Mar 24, 2026
dividend
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
<p align="justify">NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=771OWPRk8iZpS03ty8fZPQH4cYrUR1G1
Mar 9, 2026
earnings
LifeMD Reports Fourth Quarter and Full Year 2025 Results
<p align="center"><strong><em>Conference</em></strong> <strong><em>call begins at 4:30 p.m. Eastern time today</em></strong></p>
Mar 3, 2026
other
LifeMD to Participate in Two Investor Conferences During March
<p align="justify">NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LqPQnuzJdLW9H3XjAwm3Kk31yUGBY-2L